# Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Pan-Asian Women

> **NCT03296527** · PHASE3 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 1011 (actual)

## Conditions studied

- Controlled Ovarian Simulation

## Interventions

- **DRUG:** Follitropin alfa
- **DRUG:** Follitropin delta

## Key facts

- **NCT ID:** NCT03296527
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-01
- **Primary completion:** 2020-01-03
- **Final completion:** 2020-07-26
- **Target enrollment:** 1011 (ACTUAL)
- **Last updated:** 2023-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03296527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03296527, "Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Pan-Asian Women". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03296527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*